The albumin–bilirubin (ALBI) grade, as well as the Child–Pugh score, reflects liver reserve and can serve as a predictive factor in patients with HCC undergoing anticancer treatment [12,13,14]. This evidence concerns the gene ALB and hepatocellular carcinoma.